百合医疗Baihe品牌怎么样 申请店铺

我要投票 百合医疗Baihe在医疗器械行业中的票数:412 更新时间:2025-08-16
百合医疗Baihe是哪个国家的品牌?「百合医疗Baihe」是 广东百合医疗科技股份有限公司 旗下著名品牌。该品牌发源于广东省佛山市,由创始人黄 *在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力百合医疗Baihe品牌出海!将品牌入驻外推网,定制百合医疗Baihe品牌推广信息,可以显著提高百合医疗Baihe产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

百合医疗Baihe怎么样

广东百合医疗科技股份有限公司,创办于1999年,位于佛山市南海区狮山镇桃园东路89号。公司主营业务为一次性使用医用耗材等医疗器械的研发、生产和销售,是一家现代工程技术和临床医学相结合的企业,是国内高端医用耗材领域能够与国外产品形成强有力竞争的为数不多的企业之一。

公司拥有国内先进的医用耗材生产工艺和技术,完善的质量保证体系,现代化的管理手段以及高品质的产品和优质的服务。从公司创立之初的中心静脉导管和血液透析导管起步,截止目前,公司已经形成静脉输液耗材、血液净化耗材、护创敷料耗材三大领域,并依托三大领域的技术优势和丰富的产品储备,成为上述领域内的一次性使用医用耗材综合解决方案提供商。

公司聚集了由陈建华等医用耗材专家领衔的高水平专业研发和技术创新团队,人才储备充足,专业涵盖医用高分子材料、生物医学工程、临床医学、检验医学、生命科学、生物化学、材料学、模具、机械等多个学科。公司主要产品有:中心静脉导管、血液透析导管、输液接头、延长管、旋塞、留置针、血液回路、内瘘穿刺包、压力传感器等三类医疗器械。

产品已经销往世界各地,其中中心静脉导管及血液透析导管两个主导产品国内市场占有率均较高。

公司获得包括华南理工大学、暨南大学、中山大学附属医院、南方医科大学珠江医院等院校及各级政府机构和社会各界的关注和支持,使得百合医疗对医用导管产品的基础研究和临床试用得以顺利开展,并取得长足进步。

公司将继续秉承“注重信誉,对生命负责;追求卓越,让顾客满意”的价值观,坚持以“用户为中心”的设计理念,继续致力于一次性使用医用耗材等医疗器械的研发、生产和销售。公司将本着“为患者负责”的精神,精益求精,争取早日跻身世界领先的一次性使用医用耗材综合解决方案提供商行列。


Guangdong Baihe Medical Technology Co., Ltd., founded in 1999, is located at No. 89, Taoyuan East Road, Shishan town, Nanhai District, Foshan City. The main business of the company is the research and development, production and sales of disposable medical consumables and other medical devices. It is an enterprise combining modern engineering technology and clinical medicine, and one of the few enterprises in the domestic high-end medical consumables field that can form strong competition with foreign products. The company has advanced production technology and technology of medical consumables, perfect quality assurance system, modern management means, high-quality products and high-quality services. From the beginning of the company's establishment, the central venous catheter and hemodialysis catheter started. Up to now, the company has formed three major fields: intravenous infusion consumables, blood purification consumables and nursing wound dressing consumables. Relying on the technical advantages and rich product reserves of the three fields, the company has become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R & D and technical innovation team led by Chen Jianhua and other medical consumables experts, with sufficient talent reserve, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life science, biochemistry, materials science, mold, machinery and other disciplines. The company's main products are: central venous catheter, hemodialysis catheter, infusion connector, extension tube, cock, indwelling needle, blood circuit, internal fistula puncture bag, pressure sensor and other three types of medical devices. The products have been sold all over the world, and the two leading products of central venous catheter and hemodialysis catheter have a high market share in China. The company has obtained the attention and support from colleges and universities including South China University of technology, Jinan University, Affiliated Hospital of Sun Yat sen University, Pearl River Hospital of Southern Medical University, as well as government agencies at all levels and all sectors of the society, which makes Lily medical carry out the basic research and clinical trial of medical catheter products smoothly and make great progress. The company will continue to adhere to the values of "pay attention to reputation, be responsible for life; pursue excellence, make customers satisfied", adhere to the design concept of "user centered", and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. In the spirit of "being responsible for patients", the company will strive for perfection and become one of the world's leading providers of comprehensive solutions for disposable medical consumables as soon as possible.

本文链接: https://brand.waitui.com/c48592003.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

宇树科技CEO王兴兴:我们确实很缺人

“我们确实很缺人,这也是部分同事近期非常辛苦的原因。”宇树科技CEO王兴兴8月15日在2025世界人形机器人运动会赛后透露了公司未来的人才布局。他表示,目前大部分员工在杭州,后续会根据情况设立分公司,而且在积极招募优秀人才。(上证报)

2小时前

OpenAI员工寻求按5000亿美元估值出售大约60亿美元

据报道,OpenAI员工寻求按5000亿美元估值出售大约60亿美元。包括日本软银集团、Thrive、Dragoneer在内,一个投资者团体将参与他们的股票出售,从而投资OpenAI。软银近期完成10亿美元投资,并参与了其他交易。(财联社)

2小时前

美股三大指数收盘涨跌不一,道指、标普500指数均一度创盘中历史新高

36氪获悉,美股三大指数收盘涨跌不一,均录得周线2连涨。纳指跌0.4%,本周累涨0.81%;标普500指数跌0.29%,本周累涨0.94%;道指涨0.08%,本周累涨1.74%。其中,道指、标普500指数均一度创盘中历史新高。大型科技股涨跌不一,英特尔涨约3%,奈飞、谷歌、亚马逊、Meta小幅上涨;特斯拉跌超1%,微软、苹果、英伟达小幅下跌。

2小时前

Anthropic按照1700亿美元估值融资至多50亿美元

据彭博社报道,知情人士透露,Anthropic按照1700亿美元估值融资至多50亿美元,由投资公司Iconiq Capital领投。(华尔街见闻)

2小时前

百亿级债券ETF持续扩容

债券指数化投资浪潮席卷市场。目前,债券ETF总规模近5400亿元,创下历史新高,其中,规模破百亿元的债券ETF高达24只。作为债券ETF新品种,上市1个月左右,首批科创债ETF的规模已超1100亿元,首只200亿元级科创债ETF也已诞生。与此同时,第二批科创债ETF渐行渐近,多家基金公司正紧锣密鼓地筹备上报工作。(上证报)

2小时前

本页详细列出关于百合医疗Baihe的品牌信息,含品牌所属公司介绍,百合医疗Baihe所处行业的品牌地位及优势。
咨询